BioCatalyst

KPTI — Karyopharm Therapeutics Inc. catalysts

2 verified catalyst event(s) for Karyopharm Therapeutics Inc. (ticker KPTI). Each is linked to its official source. Verified as of 2026-06-22.

Next verified catalyst

2026-08-01 — Selinexor in Maintenance Therapy After Systemic Therapy for Participants With p53 Wild-Typ · official source ↗

Upcoming

DateEventCompanyDrugOfficial source & verification
2026-08 (month)
in 1mo
ESTIMATED
 READOUT
Selinexor in Maintenance Therapy After Systemic Therapy for Participants With p5
Phase 3 · Endometrial Cancer
 KPTI Karyopharm Therapeutics Inc. Selinexor, Matching Placebo for selinexo ClinicalTrials.gov ↗
✓ Source-checked 2026-06-22
Sponsor-projected date — can change
2026-09 (month)
in 2mo
ESTIMATED
 READOUT
A Study to Evaluate Single Agent Selinexor Versus Physician's Choice in Particip
Phase 2 · Myelofibrosis
 KPTI Karyopharm Therapeutics Inc. Selinexor, Physician's Choice Treatment ClinicalTrials.gov ↗
✓ Source-checked 2026-06-22
Sponsor-projected date — can change
Disclaimer. Bio Catalyst Calendar is a public-events data calendar. Every date is sourced and linked to an official record (ClinicalTrials.gov, FDA / Federal Register, openFDA). It is scheduling and reference data only — NOT investment advice, a recommendation, or a buy/sell signal. Dates set by sponsors and the FDA can change; always confirm against the linked official source.